(Q80985181)

English

Randomized trial of bevacizumab in advanced renal cell carcinoma

scientific article published on 01 March 2008

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18377821

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377821%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 January 2020

title

Randomized trial of bevacizumab in advanced renal cell carcinoma (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18377821

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377821%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

1 reference

Ronald M Bukowski

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18377821

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377821%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 January 2020

publication date

1 March 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18377821

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377821%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 January 2020

published in

Current Oncology Reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18377821

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377821%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 January 2020

volume

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18377821

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377821%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 January 2020

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18377821

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377821%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 January 2020

page(s)

99-100

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18377821

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18377821%20AND%20SRC:MED&resulttype=core&format=json

retrieved

5 January 2020

exact match

https://scigraph.springernature.com/pub.10.1007/s11912-008-0016-9

0 references

cites work

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18377821

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of VHL gene mutation in human cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18377821

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of metastatic renal cell carcinoma with a combination of bevacizumab and erlotinib

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18377821

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase II study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal cell cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18377821

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

(Q80985181)

Randomized trial of bevacizumab in advanced renal cell carcinoma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)